Detoxification of electrophilic compounds by glutathione S-transferase catalysis: Determinants of individual response to chemical carcinogens and chemotherapeutic drugs?

BioFactors

Volumn 17, Issue 1-4, 2003, Pages 115-130

  Coles, Brian F ^a   Kadlubar, Fred F ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; GLUTATHIONE TRANSFERASE; METHOTREXATE; POLYCYCLIC AROMATIC HYDROCARBON;

ACCURACY; ALKYLATION; ALLELE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RISK; CANCER SUSCEPTIBILITY; CATALYSIS; COLORECTAL CANCER; CONFERENCE PAPER; DISEASE ASSOCIATION; DRUG DETOXIFICATION; DRUG RESPONSE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTOXICITY; GENOTYPE; HOMEOSTASIS; HUMAN; HYPOTHESIS; LUNG CANCER; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REACTION ANALYSIS; RISK ASSESSMENT; TISSUE DISTRIBUTION; TISSUE SPECIFICITY;

EID: 0142012164     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520170112     Document Type: Conference Paper

References (47)

1. J.D. Hayes and D.J. Pulford, The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance, Crit. Rev. Biochem. Molec. Biol. 30 (1995), 445-600.
2. B. Coles and B. Ketterer, The role of glutathione transferases in chemical carcinogenesis, Crit. Rev. Biochem. Molec. Biol. 25 (1990), 47-70.
3. J.D. Hayes and L.I. McLellan, Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress, Free Rad. Res. 31 (1999), 273-300.
4. J.D. Hayes and R.C. Strange, Glutathione S-transferase polymorphisms and their biological consequences, Pharmacology 61 (2000), 154-166.
5. H.A.A.M. Dirven, B. van Ommen and P.J. van Bladeren, Glutathione conjugation of alkylating cytostatic drugs with a nitrogen mustard group and the role of glutathione S-transferases, Chem. Res. Toxicol. 9 (1996), 351-360.
6. S. Landi, Mammalian class theta GST and differential susceptibility to carcinogens: a review, Mutat. Res. 463 (2000), 247-283.
7. T.R. Rebbeck, Molecular Epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility, Cancer Epidemiol. Biomarkers Prevention 6 (1997), 733-743.
8. A. Inskip, J. Elexperu-Camiruaga, N. Buxton, P.S. Dias, J. MacIntosh, D. Campbell, P.W. Jones, L. Yengi, J.A. Talbot, R.C. Strange and A.A. Fryer, Identification of polymorphism at the glutathione S-transferase GSTM3 locus: evidence for linkage with GSTM1*A, Biochem. J. 312 (1995), 713-716.
9. B.F. Coles, K.E. Anderson, D.R. Doerge, M.I. Churchwell, N.P. Lang and F.F. Kadlubar, Quantitative analysis of interindividual variation of glutathione S-transferase expression in human pancreas and the ambiguity of correlating genotype with phenotype, Cancer Res. 60 (2000), 573-579.
10. B.F. Coles, F. Morel, C. Rauch, W.W. Huber, M. Yang, C.H. Teitel, B. Green, N.P. Lang and F.F. Kadlubar, Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression, Pharmacogenetics 11 (2001), 663-669.
11. B. Coles, M.Yang, N.P. Lang and F.F. Kadlubar, Expression of hGSTP1 alleles in human lung and catalytic activity of the native protein variants towards 1-chloro-2,4-dinitrobenzene, 4-vinylpyridine and (+)-anti benzo[a]pyrene-7,8-diol-9,10-oxide, Cancer Lett. 156 (2000), 167-175.
12. N. Tetlow, D. Liu and P. Board, Polymorphism of human alpha class glutathione transferases, Pharmacogenetics 11 (2001), 609-617.
13. J.D. Rowe, E. Nieves and I. Listowsky, Subunit diversity and tissue distribution of human glutathione S-transferases: interpretations based on electrospray ionization-MS and peptide sequence-specific antisera, Biochem. J. 325 (1997), 481-486.
14. B. van Ommen, J.J.P. Bogaards, W.H.M. Peters, B. Blaauboer and P.J. van Bladeren, Quantification of human hepatic glutathione S-transferases, Biochem. J. 269 (1990), 609-613.
15. W.H.M. Peters, L. Kock, F.M. Nagengast and P.G. Kremers, Biotransformation enzymes in human intestine: critical low levels in the colon? Gut 32 (1991), 408-412.
16. C.L. Berendsen, W.H. Peters, P.G. Scheffer, A.A. Boumann, E. Boven and D.W. Newling, Glutathione S-transferase activity and subunit composition in transitional cell cancer and mucosa of the human bladder, Urology 49 (1997), 644-651.
17. S. Anttila, L. Luostarinen, A. Hirvonen, E. Elovaara, A. Karjalainen, T. Nurminen, J.D. Hayes, H. Vainio and B. Ketterer, Pulmonary expression of glutathione S-transferase M3 in lung cancer patients; association with GSTM1 polymorphism, smoking, and asbestos exposure, Cancer Res. 55 (1995), 3305-3309.
18. S.S. Hecht, Tobacco smoke carcinogens and lung cancer, J. Natl, Cancer Inst. 91 (1999), 1194-1210.
19. F. Morel, O. Fardel, D.J. Meyer, S. Langouët, K.S. Gilmore, B. Meunier, C-PD. Tu, T.W. Kensler, B. Ketterer and A. Guillouzo, Preferential increase of glutathione S-transferase class α transcripts in cultured human hepatocytes by phenobarbital, 3-methylcholanthrene and dithiolethiones, Cancer Res. 53 (1993), 231-234.
20. J.J.P. Bogaards, H. Verhagen, M.I. Willems, G. van Poppel and P.J. van Bladeren, Consumption of brussels sprouts results in elevated α-class glutathione S-transferase levels in human blood plasma, Carcinogenesis 15 (1994), 1073-1075.
21. J.W. Lampe, C. Chen, S. Li, J. Prunty, M.T. Grate, D.E. Meehan, K.V. Barale, D.A. Dightman, Z. Feng and J.D. Potter, Modulation of human glutathione S-transferases by botanically defined vegetable diets, Cancer Epidemiol. Biomarkers Prevention 9 (2000), 787-793.
22. Y. Zhang and P. Talalay, Anticarcinogenic activities of organic isothiocyanates: chemistry and mechanisms, Cancer Res. 54 (1994), 1976s-1981s.
23. R.H. Kolm, H Danielson, Y Zhang, P. Talalay and B. Mannervik, Isothiocyanates as substrates for human glutathione S-transferases; structure-activity studies, Biochem. J. 311 (1995), 453-459.
24. K.R. Kaderlik, R.F. Minchin, G.J. Mulder, K.F. Ilett, M. Daugaard-Jenson, C.H. Teitel and F.F. Kadlubar, Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (PhIP) in rat extrahepatic tissues, Carcinogenesis 15 (1994), 1703-1709.
25. N.P. Lang, M.A. Butler, J. Massengill, M. Lawson, R.C. Stotts, M. Hauer-Jensen and F.F. Kadlubar, Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps, Cancer Epidemiol. Biomarkers Prevention 3 (1994), 675-682.
26. B. Coles, S.A. Nowell, S.L. MacLeod, C. Sweeney, N.P. Lang and F.F. Kadlubar, The role of human glutathione S-transferases (hGSTs) in the detoxification of the food-derived carcinogen metabolite N-acetoxy-PhIP, and the effect of a polymorphism in hGSTA1 on colorectal cancer risk, Mutat. Res. 482 (2001), 3-10.
27. D.W. Layton, K.T. Bogen, M.G. Knize, F.T. Hatch, V.M. Johnson and J.S. Felton, Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research, Carcinogenesis 16 (1995), 39-52.
28. L. Le Marchand, J. H. Hankin, L.R. Wilkens, L.M. Pierce. A. Franke, L.N. Kolonel, A. Seifried, L.J. Custer, W. Chang, A. Lum-Jones and T. Donlon, Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk, Cancer Epidemiol. Biomarkers Prevention 10 (2001), 1259-1266.
29. C. Sweeney, B.F. Coles, S. Nowell, N.P. Lang and F.F. Kadlubar, Novel markers of susceptibility to carcinogens in diet: associations with colorectal cancer, Toxicology 181-182 (2002), 83-87.
30. H.J. Lin, N.M. Probst-Hensch, A.D. Louie, I.H. Kau, J.S. Witte, S.A. Ingles, H.D. Frankl, E.R. Lee and R.W. Haile, Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas, Cancer Epidemiol. Biomarkers Prevention 7 (1998), 647-652.
31. C. Sweeney, C.B. Ambrosone, L. Joseph, A. Stone, L.F. Hutchins, F.F. Kadlubar and B.F. Coles. Association between a glutathione S-transferase A1 promoter polymorphism and survival after breast cancer treatment, Intl. J. Cancer 103 (2003), 810-814.
32. C. Sweeney, G.Y. McClure, M.Y. Fares, A. Stone, B.F. Coles, P.A. Thompson, S. Korourian, L.F. Hutchins, F.F. Kadlubar and C.B. Ambrosone, Association between survival after treatment for breast cancer and glutathione S-transferase P1 Ile 105Val polymorphism, Cancer Res. 60 (2000), 5621-5624.
33. C. Sweeney, L. Joseph, B.F. Coles, G.Y. McClure, P.A. Thompson, M.Y. Fares, L.F. Hutchins, F.F. Kadlubar and C.A. Ambrosone, Glutathione S-transferase (GST) P1 expression in primary breast tumors in relation to GSTP1Ile105Val genotype and survival, Proc. Amer. Assoc. Cancer Res. 42 (2001), 739.
34. C.B. Ambrosone, C. Sweeney, B, Coles, P.A. Thompson, G.Y. McClure, S. Korourian, M.Y. Fares, A. Stone, F.F. Kadlubar and L.F. Hutchins, Polymorphisms in glutathione S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer, Cancer Res. 61 (2001), 7130-7135.
35. V. Adler, Z. Yin, S.Y. Fuchs, M. Benezra, L. Rosario, K.D. Tew, M.R. Pincus, M. Sardana, C.J. Henderson, C.R. Wolf, R.J. Davis and Z. Ronai, Regulation of JNK signaling by GSTp, EMBO J. 18 (1999), 1321-1334.
36. A. Villafania, K. Anwar, S. Amar, L. Chie, D. Way, D.L. Chung, V. Adler, Z. Ronai, P.W. Brandt-Rauf, Z. Yamaizumii, H-F. Kung and M. R. Pincus, Glutathione S-transferase as a selective inhibitor of oncogenic ras-p21-induced mitogenic signaling through blockade of activation of jun by jun-N-terminal kinase, Ann. Clin. Lab. Sci. 30 (2000), 57-64.
37. C.J. Henderson, A.W. McLaren, G.J. Moffat, E.J. Bacon and C.R. Wolf, Pi-class glutathione S-transferase: regulation and function, Chemico.-Biol Interact. 111-112 (1998), 69-82.
38. J-Z. Cheng, S.S. Singhal, A. Sharma, M. Saini, Y.Yang, S. Awasthi, P. Zimniak and Y.C. Awasthi, Transfection of mGSTA4 in HL-60 cells protects against 4-hydroxynonenal-induced apoptosis by inhibiting JNK-mediated signaling, Arch. Biochem. Biophys. 392 (2001), 197-207.
39. G.A. Keating, R. Sinha, D. Layton, C.P. Salmon, M.G. Knize, K.T. Bogan, C.F. Lynch and M. Alavanj, Comparisons of heterocyclic amine levels in home-cooked meats with exposure indicators, Cancer Causes Control 11 (2000), 731-739.
40. N. Kazerouni, R. Sinha, C.H. Hsu, A. Greenberg and N. Rothman, Analysis of 200 food items for benzo[a]pyrene and estimation of its intake in an epidemiologic study, Food Chem. Toxicol. 39 (2001), 423-436.
41. S. Pavanello and E. Clonfero, Biological indicators of genotoxic risk and metabolic polymorphisms, Mutat. Res. 463 (2000), 285-308.
42. A-S. Johansson and B. Mannervik, Human glutathione transferase A3-3, a highly efficient catalyst of double-bond isomerisation of the biosynthetic pathway of steroid hormones, J. Biol. Chem. 276 (2001), 33061-33065.
43. S.K. Srivastava, S.S. Singhal, X. Hu, Y.C. Awasthi, P. Zimniak and S.V. Singh, Differential catalytic efficiency of allelic variants of human glutathione S-transferase Pi in catalyzing the glutathione conjugation of thiotepa, Arch. Biochem. Biophys. 366 (1999), 89-94.
44. G.A. Törüner, C. Akyerli, A. Uçar, T. Aki, N. Atsu, H. Özen, M. Tez, M. Çetinkaya and T. Özçelik, Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder susceptibility in the Turkish population, Arch. Toxicol. 75 (2001), 459-464.
45. A. Risch, H. Wikman, S. Thiel, P. Schmezer, L. Edler, P. Drings, H. Dienemann, K. Kayser, V. Schulz, B. Spiegelhalder and H. Bartsch, Glutathione S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas, Pharmacogenetics 11 (2001), 757-764.
46. K. Mitrunen, N. Jourenkova, V. Kataja, M. Eskelinen, V.M. Kosma, S. Benhamou, H. Vainio, M. Uusitupa and A. Hirvonen, Glutathione S-transferase M1, M3, P1 and T1 genetic polymorphisms and susceptibility to breast cancer, Cancer Epidemiol. Biomarkers Prevention 10 (2001), 229-236.
47. C.M. Maugard, J. Charrier, A. Pitard, L. Campion, O. Akande, L. Pleasants and F. Ali-Osman, Genetic polymorphism at the glutathione S-transferase (GST) P1 locus is a breast cancer risk modifier, Int. J. Cancer 91 (2001), 334-339.